| Contributors: |
Acanfora, G.; Nacchio, M.; Baronchelli, C.; Boscaino, A.; Buriani, C.; Carico, E.; Cavazzana, A.; Cesinaro, A. M.; Claudio, D.; Cozzolino, I.; Crescenzi, A.; Damiani, S.; De Chiara, G.; De Rezende, G.; De Vincentiis, L.; Fadda, G.; Ferrara, G.; Flavio, P.; Gazzano, G.; Gencarelli, A.; Grillo, F.; Guidobaldi, L.; Lai, M. L.; Magro, G.; Marangi, G.; Pagni, F.; Pennelli, G.; Piana, S.; Pirrelli, M.; Pizzolitto, S.; Renzulli, G.; Rossi, E. D.; Taccogna, S.; Uccella, S.; Ugolini, C.; Vecchione, A.; Vigliar, E.; Volante, M.; Zappacosta, R.; Zito, F. A.; Tallini, G.; Troncone, G.; Bellevicine, C. |
| Description: |
Objective. To understand the state of the art of Italian thyroid cytopathology practice, a survey was sent by the Italian Committee of cytopathology to the 846 registered emails of the Italian society of pathology and cytology (SIAPEC) members.Methods. A survey divided in 4 sections (geographic distribution, pre-analytics, diagnostic work up, molecular testing) was sent to SIAPEC members in April 2023. An additional set of questions regarding molecular analysis was sent to first round participants. Results. A total of 104/846 (12.2%) SIAPEC members replied to the survey. Non-pathologist physicians performed FNA in the majority of cases (78/104, 75%). The Italian Consensus for the Classification and Reporting of Thyroid Cytology (ICCRTC) system is adopted by most centers (94/104 90,38%), although in 32.6% it was used along with other classifications systems. Only 44/104 (42.2%) of the participants performed molecular tests on thyroid FNA, mostly upon requests from the caring physician (25/41, 61.1%). Conclusion. This survey offers a snapshot of the current Italian thyroid FNA practice. The volume of thyroid FNA performed is similar to the pre-Covid workload and the ICCRTC is the most frequently adopted classification system. Molecular tests are performed by a significant minority of participants, with different testing modalities and clinical-pathological indications. |